The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CVS | +38.7% | +19.37% | +3.6% | +51,585% |
| S&P | +13.09% | +85.73% | +13.17% | +7,048% |
The health-care company runs two business units: retail pharmacy and pharmacy benefit management.
A look at some recession-proof stocks to consider adding to your portfolio.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $102.88B | 7.8% |
| Gross Profit | $13.82B | 10.2% |
| Gross Margin | 13.43% | 0.3% |
| Market Cap | $95.62B | 20.9% |
| Market Cap / Employee | $0.32M | 0.0% |
| Employees | 300K | 0.0% |
| Net Income | -$3,990.00M | -5719.7% |
| EBITDA | $4.09B | 28.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $9.16B | 31.9% |
| Accounts Receivable | $33.88B | 15.0% |
| Inventory | 19K | 7.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $74.52B | -0.8% |
| Short Term Debt | $7.24B | -5.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 0.18% | -1.8% |
| Return On Invested Capital | 4.40% | -0.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $98.00M | 106.9% |
| Operating Free Cash Flow | $796.00M | 206.8% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 12.27 | 16.18 | 19.25 | 197.00 | 1133.04% |
| Price to Book | 0.75 | 1.13 | 1.13 | 1.23 | 17.12% |
| Price to Sales | 0.15 | 0.23 | 0.23 | 0.24 | 13.24% |
| Price to Tangible Book Value | -1.28 | -1.98 | -2.13 | -2.39 | 34.85% |
| Price to Free Cash Flow TTM | 19.17 | 33.35 | 62.62 | 32.96 | -10.60% |
| Enterprise Value to EBITDA | 38.29 | 29.52 | 34.85 | 40.63 | -15.04% |
| Free Cash Flow Yield | 5.2% | 3.0% | 1.6% | 3.0% | 11.86% |
| Return on Equity | 6.1% | 7.0% | 5.9% | 0.6% | -90.56% |
| Total Debt | $82.92B | $81.21B | $82.72B | $81.75B | -1.15% |
We also chat about Uber and its quest to become an everything app.
And a look at Live Nation Entertainment's quarterly report and the Apple/Affirm Holdings partnership.
Breaking down earnings of companies in healthcare, education, and technology.
These companies could see their sales soar as seniors increasingly choose to live in their homes longer.
CVS earnings call for the period ending December 31, 2024.
CVS earnings call for the period ending September 30, 2024.
CVS earnings call for the period ending June 30, 2024.
CVS earnings call for the period ending March 31, 2024.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
